Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation
about
Differential clinical profile of candesartan compared to other angiotensin receptor blockersEndothelial Plasticity: Shifting Phenotypes through Force FeedbackSmall molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptorDifferential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptorsLosartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental GlaucomaMechanical stretch potentiates angiotensin II-induced proliferation in spontaneously hypertensive rat vascular smooth muscle cellsMechanical dynamics in live cells and fluorescence-based force/tension sensorsTRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.Stretch-activated channel Piezo1 is up-regulated in failure heart and cardiomyocyte stimulated by AngII.Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor.Real-time visualization of heterotrimeric G protein Gq activation in living cellsGenetics of mechanosensation in the heart.Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness.In vitro effects of exercise on the heart.Mechanosensing and Regulation of Cardiac Function.Transient receptor potential c4/5 like channel is involved in stretch-induced spontaneous uterine contraction of pregnant rat.Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockersRole of shear stress and stretch in vascular mechanobiology.Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1.Varicose veins: role of mechanotransduction of venous hypertension.Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression.The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Effect of membrane tension on the physical properties of DOPC lipid bilayer membrane.G Protein-coupled Receptor Biased Agonism.AT1 receptor blocker losartan protects against mechanical ventilation-induced diaphragmatic dysfunctionMechanical stimulus alters conformation of type 1 parathyroid hormone receptor in bone cells.Molecular mechanisms of mechanosensing and their roles in fungal contact sensing.Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation via Angiotensin II Type 1 Receptor and Smad7Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targetsMolecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: insight from microarray analysisβ-Arrestin mediates the Frank-Starling mechanism of cardiac contractilityAbnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome.Review: angiotensin II type 1 receptor blockers: class effects versus molecular effectsEccentric and concentric cardiac hypertrophy induced by exercise training: microRNAs and molecular determinants.G protein-mediated stretch reception.Efficacy and safety of angiotensin II type 1 receptor blocker/calcium channel blocker combination therapy for hypertension: focus on a single-pill fixed-dose combination of valsartan and amlodipine.
P2860
Q24613321-35497BFC-2E01-4195-9D86-E9C85D1E13A2Q26767430-765BA674-36F3-493B-86B7-3A38131D3920Q28480422-67B3ECAD-DD2E-4A1F-A490-D291C92E7B58Q28533596-C422171C-1979-4DD3-86C8-F1ACF658195FQ28550525-95375FCB-0683-46F6-9289-9CA5EDD5F487Q28571873-95409FD6-8013-4217-B913-E075887B0658Q28834419-50FA6D4C-FA52-4135-BEFB-B4909771B48EQ30516435-F438A6AA-AA5C-4E9B-9231-2901CA123945Q31156054-434BF4ED-F2E5-4684-A10B-8DD188483EF0Q33850287-E8840DFC-9335-4B32-977A-7A8A10CB2F5DQ33855316-2A338AE0-9D93-4C06-9BAD-B07FC13851C1Q33914273-B5FB67B2-5FF6-44A0-8F22-10C9C7182FEEQ34167579-F020B3A1-58BA-4C5A-83D5-45F3FD857129Q34317331-7B1FB871-94CA-4322-8FDA-260B4B653B42Q34488214-6659C670-45F6-4504-A62E-E16F6CF8895CQ34615041-FB130D20-579F-4B18-9FCF-CA7AF7E7C79FQ34632608-58D452C7-D99C-41DB-8101-058C9B968D06Q34974207-18508F1A-9088-4876-9765-0FE534CF837FQ35048773-AC3356ED-E6BC-4BFA-875B-C56EBA905896Q35185443-4055BA00-D7CB-409B-B6AC-30FE10F568EDQ35251166-E8D1CB90-C828-4B39-B426-5D99B2E7EF1FQ35566740-E86E7F7B-0D5F-4C8B-80CC-394C9C391BA3Q35829875-9F5DD5A9-D7B4-4514-96E2-A2F6205EBCDCQ36099875-691EC481-4AE7-425C-8E3B-AEA52F283CAEQ36182961-883FFA55-E043-4C4A-972B-F31A7601C110Q36241932-A21C7A4D-D0E1-476B-9A3C-0FA236B52D58Q36614714-62397DAE-E69F-4B09-B581-0B70C37DFA2EQ36665235-B6C7C05E-EC79-448D-91BB-4FE8B8FCD14CQ36752364-0737DAE1-1641-47FC-B36C-BF856665F564Q37216821-452C2657-8976-4349-81D2-DB8A9012A383Q37234988-80F7FDFC-BA0E-4AF5-8E07-6446FEF4D6C7Q37310715-FB1CFDB3-E29F-40DC-99DD-3970BEFFABB4Q37317295-8E09DE1B-0AB0-473B-8EE9-0407C005025DQ37319355-9180C228-0E18-40CE-BDBA-957DF1C31D50Q37514915-387F2D39-3680-4885-9639-D1B0EF1E36DFQ37602214-ED564BE7-B773-412A-AD7E-BB4CAD5565ECQ37770171-2788F83E-D70F-4FE2-9FE6-0FC3F9851723Q37924622-D6249636-DF3D-43B6-9C4B-19A7914B219AQ37973988-7BB47F71-C995-430A-9E6B-D7391B05B22AQ37994857-F06EC6B4-4558-4A3F-B7DB-3686DB5C393D
P2860
Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Conformational switch of angio ...... ical stress-induced activation
@ast
Conformational switch of angio ...... ical stress-induced activation
@en
Conformational switch of angio ...... ical stress-induced activation
@en-gb
Conformational switch of angio ...... ical stress-induced activation
@nl
type
label
Conformational switch of angio ...... ical stress-induced activation
@ast
Conformational switch of angio ...... ical stress-induced activation
@en
Conformational switch of angio ...... ical stress-induced activation
@en-gb
Conformational switch of angio ...... ical stress-induced activation
@nl
prefLabel
Conformational switch of angio ...... ical stress-induced activation
@ast
Conformational switch of angio ...... ical stress-induced activation
@en
Conformational switch of angio ...... ical stress-induced activation
@en-gb
Conformational switch of angio ...... ical stress-induced activation
@nl
P2093
P2860
P3181
P356
P1433
P1476
Conformational switch of angio ...... ical stress-induced activation
@en
P2093
Haruaki Nakaya
Hiroshi Akazawa
Keijiro Saku
Koichi Fukuzaki
Masahiro Fujino
Naoki Mochizuki
Noritaka Yasuda
Satoshi Imaizumi
P2860
P304
P3181
P356
10.1038/SJ.EMBOR.7401157
P407
P50
P577
2008-02-01T00:00:00Z